NCT04363047

Immune Cells in Inflammatory Arthritis With Coronaviruses, Including COVID-19

Immune Cells and the Coronavirus for Inflammatory Arthritis

• Status: Enrolling By Invitation
• Phase: —
• Study type: Observational
• Enrollment: 125 (estimated)
• Sponsor: University of Manchester · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: —

Summary

A team at the University of Manchester are developing a test that tcould be helpful in detecting immunity to the Coronavirus (which causes the COVID-19 disease) in participants with inflammatory arthritis. It is based on a flu assay has already developed; the team will replace the flu antigen with a Coronavirus antigen to see if it is effective. This project aims to develop a test to see if people who have had the virus have developed immunity to it. This could help to predict who might or might not get the disease a second time, who should stay at home to be protected from potential infection or who will not develop any symptoms, even if exposed to the virus. When vaccination trials against the Coronavirus will be launched, this test could also help to see if the vaccine is effective.

Conditions

• SARS Virus

Interventions

Type	Name	Description
OTHER	40ml blood sample	We'll be collecting cells, DNA and serum.

Timeline

• Start date: 2020-10-01
• Primary completion: 2026-07-31
• Completion: 2026-07-31
• First posted: 2020-04-27
• Last updated: 2024-05-08

Locations

1 site across 1 country: United Kingdom